PositiveID Corporation appoints new president
Probst has 15 years of managerial experience with large biodetection products and programs. He joined PositiveID when the company acquired Microfluidic Systems in 2011.
"Over the past three years, our team has accomplished several significant milestones, including teaming with major government contractors, receiving a $2.5 million license fee from a large partner, and last month entering into a strategic contract to demonstrate our M-BAND product in a Defense Department program," Probst said. "I am confident that our best-in-class technology, partners, and capabilities position us well for success."
Prior to joining Microfluidic Systems, Probst directed biodetection programs at Lawrence Livermore National Laboratory, where he helped to develop and deploy the BioWatch program. He previously served as the director of capillary electrophoresis and chemistries at the Joint Genome Institute.
"Lyle's performance and results speak for themselves," William Caragol, the chairman and CEO of PositiveID, said. "I am proud of what Lyle and the team have achieved and we are eager to reach the major goals we've set for 2014 and beyond."
PositiveID Corporation develops biological detection systems and rapid biological tests for the U.S. homeland defense industry.